leisure time -WSS

leisure time

author：leisure time 2025-10-01 21:10:17 - browse：12434

A syringe injects into a segment of DNA — biotech coverage from STAT — Adobe

Two congenitally deaf children can hear for the first time after being treated with gene therapy, according to data presented at a conference Wednesday.

The results are “jaw-droppingly good, just shocking how good. It exceeded the wildest expectations of anybody who started this work,” said Larry Lustig, an otolaryngologist at Columbia University and an investigator on the study.

The new data come from a larger study by Regeneron Pharmaceuticals that will treat nearly two dozen children with a specific type of congenital hearing loss with gene therapy. The clinical trial is meant to measure safety and efficacy of DB-OTO, a gene therapy drug Regeneron is developing to treat children who have hearing loss due to changes in the otoferlin gene. Several teams are targeting this rare form of congenital deafness that affects 1% to 8% of deaf people globally, including a team with Akouos, an Eli Lilly subsidiary, which successfully treated an 11-year-old boy with a similar gene therapy. Lustig calls this the “lowest of the low-hanging fruit” for gene therapy deafness treatments.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Doulas covered by Medicaid under New York's new plan

hotspot

WSS

Prince Harry seeks over $550,000 in phone hacking lawsuit against British tabloid publisher

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Brazil's Jair Bolsonaro is barred from running for office until 2030

The nurse manager staffing crisis is hurting patients

Caregivers of transplant patients call for more support, training

How I ended up pumping milk in a bathroom stall at JPM 2024

Wikipedia

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

Cancer drug shortages should be causing more outrage

Eating disorder hotline's move to chatbot carried cost for volunteers

Moonlake's readout produced a cash windfall. Risks remain

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

Heart attack and stroke risk calculators need revising

Eating disorder hotline's move to chatbot carried cost for volunteers

Dobbs anniversary: the lost opportunity of abortion as health care

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

What does generative AI mean for health care? We asked experts

Risky weight loss products often used by teens globally, per study

explore

Doulas covered by Medicaid under New York's new plan

Brazil's Jair Bolsonaro is barred from running for office until 2030

GOP inquiry over gain

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

Caregivers of transplant patients call for more support, training

hotspot

entertainment

hotspot

leisure time